Does the manufacturer offer OEM or ODM services?

Yes, both OEM and ODM services are available.

What certifications does the product hold?

The product holds CCC, CE, ISO, QS, RoHS, and HACCP certifications.

What are the key ingredients?

Main ingredients include Mannan-oligosaccharide, Si-Al-Acid salt derivatives, Biopolymer, and Vitamin C.

Vitamin Anti- Mycotoxin Mannan-Oligosaccharide Animal Feed Additive

Name: Vitamin Anti- Mycotoxin Mannan-Oligosaccharide Animal Feed Additive
Brand: Shandong Sinder Technology Co., Ltd
SKU: 2028418015

Shandong, ChinaShandong Sinder Technology Co., Ltd

US$0.10-30.00

3,500 Bags

Sample price:US$0.10/piece.Request sample

Product profile

Customization

Available

Certification

CCC, CE, ISO, QS, RoHS, HACCP

Element

Vitamin C

Model NO.

Anti- mycotoxin

Shape

Powder

Type

Amino Acid

Animals

Chicken

Animal2

Swine

Animal3

Duck

Animal4

Goose

Animal5

Turkey

Animal6

Cow

Animal7

Broiler

Animal8

Aquatic Animals

Animal9

Fish

Storage

Cool&Dry

Precautions

Moisture

Content1

Mannan-Oligosaccharide

Content2

Vitamin C

Content3

Si-Al-Acid Salt Derivatives

Function

Ant-Microbials

Transport Package

Bag

Specification

500g/bag

Trademark

Sinder

Origin

Zhucheng City, China

HS Code

23099010

Production Capacity

100000g/Year

Key features

Multi-Function Protection: Absorbs mycotoxins, eliminates toxins, reduces stress, improves immunity, and protects liver and kidneys.

Broad Species Applicability: Suitable for poultry, swine, cattle, aquatic animals, and other breeding livestock.

Long Shelf Life: Guaranteed 2-year expiry period when stored in a cool, dry place.

Multiple Certifications: Certified by CCC, CE, ISO, QS, RoHS, and HACCP standards.

OEM/ODM Services: Customization services available with 154 R&D engineers and extensive production capacity.

Fast Acting Formula: Quickly effective in reducing mycotoxin concentration and preventing intestinal diseases.

Feed Improvement: Enhances feed palatability and raises production traits while protecting nutritional ingredients.

Company profile

Shandong Sinder Technology Co., Ltd

Shandong, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service AvailableExport Year: 2013-03-01 CertifiedNearest Port: Qingdao PortAverage Response Time: >24h CertifiedTerms of Payment: LC, T/T

AI-Powered supplier vetting

SummaryShandong Sinder Technology Co., Ltd. is a China-based foreign joint venture established in 1999, with 1,200 employees and operations focused on animal health, vaccines, medicines, feed additives, and herbal products. The available information indicates substantial production capacity, including nine production lines and stated annual outputs for vaccines, medicines, feed additives, and herbal products. It holds ISO9001:2015 and ISO14001:2015 certifications, and its disclosed R&D and quality-control staffing supports technical and quality capabilities. Innovation evidence includes large-scale cell suspension culture for highly pathogenic avian influenza vaccines. Export activity is documented from 2013, with markets across multiple regions, although exports represent only 1%–10% of total sales. Evidence is insufficient to assess after-sales service, customization capability, and broader customer-case depth. Financial credibility cannot be assessed because financial figures are excluded.

Supplier typeThe supplier is identified as Shandong Sinder Technology Co., Ltd., a China-based foreign joint venture established in 1999. Its business scope covers health and medicine, chemicals, agriculture and food, with product keywords centered on animal vaccines, veterinary medicines, feed additives, detection kits, and herbal products.

CertificationsThe supplier information explicitly lists ISO9001:2015 and ISO14001:2015 certificates, along with other unspecified certifications. This provides direct evidence of certified quality-management and environmental-management systems.

R&D capabilityThe supplier reports 154 R&D engineers, and its company description states that it was the first worldwide to achieve large-scale cell suspension culture of highly pathogenic avian influenza vaccine for animals. The disclosed production workshop was also described as the first approved by China’s Ministry of Agriculture and Rural Affairs for this technology, providing strong evidence of specialized innovation capability.

Production capacityThe supplier operates nine production lines, has a 73,279 m² manufacturing plant, employs 1,200 people, and reports annual outputs of 2,000 tons each for live and killed vaccines, 4,000 tons of medicine, 10,000 tons of feed additives, and 5,000 tons of herbal products. These stated facilities, workforce, production lines, and output figures directly support substantial production capability.

Client casesThree transaction records identify CÔNG TY TNHH THƯƠNG MẠI ANIVACC in Vietnam as an associated buyer, involving PCV2-related pig vaccine products and at least one recorded transaction. This confirms a documented buyer relationship, but the evidence is limited to one named buyer and does not demonstrate a broad portfolio of customer cases or project outcomes.